Rituximab maintenance improves outcomes in follicular lymphoma

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1568, 2006-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab: As First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma

By Croxtall Jamie D.

Drugs, Vol. 71, Iss. 7, 2011-05 ,pp. : 885-895

Adis International

Access to resources Recommend Favorite

NICE recommends rituximab for follicular lymphoma . . .

Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic Evaluation

By Deconinck Eric

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 35-46

Adis International

Access to resources Recommend Favorite

Rituximab long-term efficacy for follicular lymphoma confirmed

Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Rituximab: A Review of its Use in Chronic Lymphocytic Leukaemia, Low-Grade or Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

By Keating Gillian M.

Drugs, Vol. 70, Iss. 11, 2010-07 ,pp. : 1445-1476

Adis International

Access to resources Recommend Favorite